Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-10.78	72.01	80.71
Graham Fair Price	-11.75	26.52	30.05
PEG	103.47	-0.96	0.47
Price/Book	11.68	-11.79	-13.35
Price/Cash Flow	-28.20	76.08	105.95
Prices/Earnings	24.61	24.84	19.93
Price/Sales	-9.55	50.18	55.48
Price/FCF	-28.20	76.08	105.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.03	0.87	0.87
Operating Margin	-0.01	0.67	0.67
ROA	-25.77	0.11	0.15
ROE	-0.17	-0.12	29.12
ROIC	1.25	1.24	-0.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-77.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	0.01	28.99
EPS QOQ	0.42	-0.26	-38.76
FCF QOQ	-0.08	0.27	237.54
Revenue QOQ	0.01	0.01	-5.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	87.40	100.26	14.72
Days Sales Outstanding (DSO)	3.22	1.85	-42.50
Inventory Turnover	1.03	0.90	-12.83
Debt/Capitalization	8.30	11.22	35.18
Quick Ratio	0.79	0.77	-2.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-15.48	-16.23	-4.82
Cash	9.07	9.17	1.13
Capex	-0.05	-0.04	23.00
Free Cash Flow	1.95	2.51	28.93
Revenue	3.72	3.81	2.36
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.81	-2.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.55	3.76	-32.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating